Free EHR, EHR and Healthcare IT Newsletter Want to receive the latest updates on EHR, EMR and Healthcare IT news sent straight to your email? Get all the latest EHR News for FREE!

Health Catalyst Eliminates Client Restrictions on Solicitation and Hiring in its Contracts

Salt Lake City – June 21, 2016 Health Catalyst, a leader in healthcare data warehousing, analytics and outcomes improvement, today announced it is eliminating the provision in its standard client service contracts that prohibits its clients from soliciting for hire or hiring Health Catalyst team members.  Health Catalyst will continue to honor restrictions preventing solicitation of client employees by Health Catalyst.

“We are committed to working with our clients as long-term partners, and focusing on long-term customer success is our first operating principle,” said Dan Burton, CEO of Health Catalyst. “Our contractual restriction to prevent clients from soliciting or hiring our team members puts up a wall between us and our clients that could inhibit our work together. We want to eliminate any barriers that might prevent our clients from achieving and sustaining clinical and financial outcomes improvements.”

This is Health Catalyst’s second move in recent months to cement a culture of open collaboration and partnership among its clients and its team members. In May, the company officially removed the non-compete provision from its standard employment agreements that prohibited its team members from being employed by organizations that compete with Health Catalyst following employment with Health Catalyst, and announced that it would not seek to enforce such non-compete provisions in existing employment agreements.

“Our company’s purpose is to enable outcomes improvement at scale,” Burton continued. “If in some instances that purpose can be furthered by our clients hiring one of our team members, and this is of interest to our team members then we don’t want to prevent that. In fact, we view it as a sincere compliment when our clients value our team members’ contributions so highly that they express interest in hiring our team members.  Ultimately, we hope each of our team members remains committed to enabling outcomes improvements at scale, whether as a team member or as an alumni of Health Catalyst.  We seek to enable our team members’ long-term career success whether inside or outside the company.”

The decision to eliminate client obligations in non-solicitation clauses supports a client-focused culture that has been acknowledged by Health Catalyst clients and by third-party industry analysts. In its latest report on healthcare business intelligence, Enterprise Healthcare BI: The Search for Outcomes,”  KLAS Research revealed that Health Catalyst’s “strategy of prioritizing client relationships and outcomes result[ed] in the highest client reviews of any vendor for insights and outcomes.”

The decision also supports a work culture that has received recognition as one of the nation’s best from organizations including Gallup, Glassdoor, Modern Healthcare, Becker’s Healthcare and Rock Health.

About Health Catalyst

Health Catalyst is a mission-driven data warehousing, analytics and outcomes-improvement company that helps healthcare organizations of all sizes perform the clinical, financial, and operational reporting and analysis needed for population health and accountable care. Our proven enterprise data warehouse (EDW) and analytics platform helps improve quality, add efficiency and lower costs in support of more than 70 million patients for organizations ranging from the largest US health system to forward-thinking physician practices. For more information, visit https://www.healthcatalyst.com, and follow us on Twitter, LinkedIn and Facebook.

June 21, 2016 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 10 blogs containing over 8000 articles with John having written over 4000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 16 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

Survey: Hospitals Progressing Slowly toward Medicare’s Goal of 50 Percent Value-Based Reimbursement by 2018

Respondents cite analytics as most important success factor for value-based reimbursement

SALT LAKE CITY – MAY 9, 2016 – Fewer than a quarter of U.S. hospitals are on track to hit the Obama Administration’s 2018 goal of providing at least half their patient care through so-called “value-based” arrangements – structures that tie reimbursement from Medicare to the quality of care patients receive.

That is one finding of a new online survey of healthcare executives representing 190 U.S. hospitals with a total of more than 20,000 licensed beds. The survey by Health Catalyst revealed that just 3 percent of health systems today meet the target set by the Centers for Medicare and Medicaid Services (CMS). Only 23 percent expect to meet it by 2019, a year after CMS had hoped that half of all Medicare reimbursements would be value-based.

According to the survey, the majority of health systems—a full 62 percent—have either zero or less than 10 percent of their care tied to the type of risk-based contracts identified by CMS as “value-based,” including Medicare accountable care organizations (ACOs) and bundled payments. Not surprisingly, small hospitals with fewer than 200 beds comprised the majority of those reporting no at-risk contracts. A contributing factor may be that smaller hospitals are five times less likely than larger organizations to have access to sufficient capital to make risk-based contracting work, according to the survey.

Despite lagging behind the federal government’s goal, healthcare executives across the board intend to steadily increase value-based care and at-risk contracts. In the next three years, all but 1 percent of respondents expect their organizations to be engaged in at-risk contracts. Sixty-eight percent said they expect risk-based contracts to account for less than half their total care in that time frame. Only 23 percent expect value-based care to account for more than half of their care in the next three years. Eight percent of respondents said they could not predict the answer.

Analytics tops the list of must-haves

The most important organizational element needed for success with risk-based contracting is analytics, said responding executives at both small and large hospitals. In fact, 52 percent of respondents cited the prime importance of analytics, more than double the second most-selected answer: a culture of quality improvement. Twenty-four percent of respondents cited cultural alignment on quality as having the most impact on value-based care success.

“Transitioning from fee-for-service reimbursement to value-based payments is a goal that many healthcare organizations embrace but are having difficulty implementing as they juggle a number of other high priorities,” said Bobbi Brown, Health Catalyst vice president of financial engagement. “This survey reveals that they’re making progress but they could use a little help – some of it financial and some of it technical in the way of better analytics to help identify at-risk populations and better manage their risk. The bottom line seems to be that while progress is slow, healthcare leaders are committed to making value-based care work.”

Survey results reflect the opinions of 78 healthcare professionals who responded to an online survey by Health Catalyst in May 2016. Over half of the respondents (51 percent) were CEOs or CFOs of large hospital-owned physician groups and hospitals ranging in size from 15 acute care beds to over 1,000 beds. The remaining respondents all held executive roles, including several Chief Medical Information Officers, Chief Medical Officers and Chief Nursing Officers.

The organizations represented include many well-known multi-hospital and multi-state health systems with a cumulative 756 inpatient and outpatient facilities and 20,416 acute care beds.

About Health Catalyst

Health Catalyst is a mission-driven data warehousing, analytics and outcomes-improvement company that helps healthcare organizations of all sizes perform the clinical, financial, and operational reporting and analysis needed for population health and accountable care. Our proven enterprise data warehouse (EDW) and analytics platform helps improve quality, add efficiency and lower costs in support of more than 70 million patients for organizations ranging from the largest US health system to forward-thinking physician practices. For more information, visit https://www.healthcatalyst.com, and follow us on Twitter, LinkedIn andFacebook.  

June 9, 2016 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 10 blogs containing over 8000 articles with John having written over 4000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 16 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

Healthcare Providers’ Analytics Needs Remain Ahead of Vendor Capabilities

Chilmark Research’s latest report finds that the pace of development of analytics solutions has yet to match the pace set by rapidly changing payment models.
 

Boston, MA, February 3, 2016 -Chilmark Research’s latest report, 2016 Analytics for Population Health Management Market Trends Report, reveals that vendor solutions are not keeping pace with the accelerating demands of a rapidly transforming industry. While vendors continue to make progress in the functional evolution of their analytics solutions, healthcare organizations (HCOs) struggle with the complexity of their data management requirements and embedding analytical insights into clinical workflows in support of strategic initiatives. This extensive update to the 2014 edition builds on Chilmark’s comprehensive review of available solutions to serve the analytics needs of HCOs to enable their Population Health Management (PHM) strategies. The report also presents a new model for understanding the value chain for clinical analytics across the enterprise.

The most important driver underlying strong growth in data analytics is the move to alternative payment models, often referred to as value-based reimbursement (VBR). Future financial success in the VBR realm requires HCOs to effectively manage risks, utilization and costs while concurrently improving quality and optimizing outcomes. Today, however, HCOs must straddle the two different payment regimes of fee-for-service (FFS) and VBR. Analytics solutions are currently focusing on helping HCOs maximize revenue (hitting quality targets) and leverage traditional FFS reimbursements (closing care gaps). A secondary objective is to help HCOs reduce medical costs (variability) and unnecessary utilization (readmissions reduction and low-acuity, non-emergent utilization).

The report points to an important, ongoing challenge – incorporating analytics into existing workflows. While vendors have made progress with analytics functionality, workflow integration ultimately keeps analytics out of the hands of clinicians who could benefit most from insights at the point of care. Today, clinicians typically exit their EHR, toggling to a clinical portal for analytically-derived insights.

Another notable finding is the relatively rapid progress made by EHR vendors in the last year. Vendors such as Cerner, Epic, and eClinicalWorks have added functionality and seen strong adoption by their customers. Independent vendors are not standing still. They continue to enhance their solutions and acquire new customers, staying one step ahead of the EHR vendors on functionality. EHR vendors, however, hold the advantage of existing customer relationships and often better ability to embed insights into clinician workflow.

According to Jody Ranck, Chilmark analyst and co-author of the report, “We still see much of the analytics market in an immature stage of development. A major obstacle is a lack of sound governance and data curation strategies that enable health care organizations to leverage their data and analytics capabilities across the entire data analytics value chain. The market is at a pivot point where we will need to see more Chief Analytics Officers and the rhetoric of ‘data-driven organizations’ manifested in reality.”

The report is available to subscribers of the Chilmark Advisory Service or may be purchased separately. For more information, visit www.chilmarkresearch.com/reports. Direct inquiries for purchase should be addressed to Sean Campbell atsean@chilmarkresearch.com.

About Chilmark Research
Chilmark Research is the only industry analyst firm focusing solely on the most transformational trends in healthcare IT. We combine proven research methodologies with intelligence and insight to provide cogent analyses of the emerging technologies that have the greatest potential to improve healthcare. We do not shy away from making tough calls, and are respected in the industry for our direct and thoughtful commentary. For more information visit: www.chilmarkresearch.com

Vendors Profiled: The Advisory Board Company, Aetna ActiveHealth, Aetna HDMS, Arcadia Healthcare Solutions, Caradigm, CareEvolution, Cerner Corporation, Conifer Health Solutions, eClinicalWorks, Epic Systems Corporation, Geneia LLC, Health Catalyst, HealthEC, IBM Watson Health, McKesson, Optum, Oracle, Orion Health, Premier, Inc., SAP, Tableau, Transcend Insights, Truven Health Analytics, Verisk Health, Wellcentive, Inc.

February 3, 2016 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 10 blogs containing over 8000 articles with John having written over 4000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 16 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

Independent Practices Outperform Industry in ICD-10 Transition

Kareo handled more than 6.6 million ICD-10 claims, representing more than $735M in claims value

IRVINE, Calif.–Kareo, the leading provider of cloud-based solutions for independent medical practices, today announced that 99 percent of claims submitted in the first month of the ICD-10 coding transition were successful. Additionally, 87 percent of Kareo customers have already been paid for at least one submitted claim.

“In October, we saw close to 6.6 million electronic claims representing more than $735 million submitted through Kareo using the ICD-10 coding scheme,” said David Mitzenmacher, Vice President of Customer Success at Kareo. “Based on our data, independent practices using Kareo handled the transition with ease, a testament to their preparation efforts. Compared to results released by the Centers for Medicare and Medicaid Services (CMS) for October, practices using Kareo appear to have outperformed the larger healthcare industry in terms of the ICD-10 transition.”

Kareo also surveyed its customer base directly to gauge its experience with the transition. Based on customer responses, 57 percent of respondents considered the ICD-10 transition “easy” or “very easy.” Just three percent of respondents considered the transition “difficult,” or “very difficult.” The remaining 40 percent considered the event “moderate.”

To summarize, Kareo and its customers have seen:

  • 6.6 million ICD-10 claims submitted in the first month
  • 99% of customers submitted at least one ICD-10 claim
  • 87% of customers received payment for at least one ICD-10 claim
  • 1.4 million claims submitted in October were already paid
  • 11 days was the average time to payment for ICD-10 claims

In the years leading up to the October 1 deadline, Kareo has supported its clients through training and software upgrades to ensure independent practices were able to go through this transition without losing or significantly delaying revenue. To learn more about how Kareo is continuing to help independent practices succeed through the transition visit http://www.kareo.com/icd-10.

November 5, 2015 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 10 blogs containing over 8000 articles with John having written over 4000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 16 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

Watson to Gain Ability to “See” with Planned $1B Acquisition of Merge Healthcare

Deal Brings Watson Technology Together with Leader in Medical Images

Armonk, NY and CHICAGO — [August 6, 2015]:  IBM (NYSE: IBM) today announced that Watson will gain the ability to “see” by bringing together Watson’s advanced image analytics and cognitive capabilities with data and images obtained from Merge Healthcare Incorporated’s (NASDAQ: MRGE) medical imaging management platform.  IBM plans to acquire Merge, a leading provider of medical image handling and processing, interoperability and clinical systems designed to advance healthcare quality and efficiency, in an effort to unlock the value of medical images to help physicians make better patient care decisions.

Merge’s technology platforms are used at more than 7,500 U.S. healthcare sites, as well as most of the world’s leading clinical research institutes and pharmaceutical firms to manage a growing body of medical images.  The vision is that these organizations could use the Watson Health Cloud to surface new insights from a consolidated, patient-centric view of current and historical images, electronic health records, data from wearable devices and other related medical data, in a HIPAA-enabled environment.

Under terms of the transaction, Merge shareholders would receive $7.13 per share in cash, for a total transaction value of $1 billion.  The closing of the transaction is subject to regulatory review, Merge shareholder approval, and other customary closing conditions, and is anticipated to occur later this year.  It is IBM’s third major health-related acquisition – and the largest – since launching its Watson Health unit in April, following Phytel (population health) and Explorys (cloud based healthcare intelligence).

“As a proven leader in delivering healthcare solutions for over 20 years, Merge is a tremendous addition to the Watson Health platform.  Healthcare will be one of IBM’s biggest growth areas over the next 10 years, which is why  we are making a major investment to drive industry transformation and to facilitate a higher quality of care,” said John Kelly, senior vice president, IBM Research and Solutions Portfolio. “Watson’s powerful cognitive and analytic capabilities, coupled with those from Merge and our other major strategic acquisitions, position IBM to partner with healthcare providers, research institutions, biomedical companies, insurers and other organizations committed to changing the very nature of health and healthcare in the 21st century. Giving Watson ‘eyes’ on medical images unlocks entirely new possibilities for the industry.”

Teaching Watson to “See” Medical Images
The planned acquisition bolsters IBM’s strategy to add rich image analytics with deep learning to the Watson Health platform – in effect, advancing Watson beyond natural language and giving it the ability to “see.”  Medical images are by far the largest and fastest-growing data source in the healthcare industry and perhaps the world – IBM researchers estimate that they account for at least 90% of all medical data today – but they also present challenges that need to be addressed:

  • The volume of medical images can be overwhelming to even the most sophisticated specialists – radiologists in some hospital emergency rooms are presented with as many as 100,000 images a day1.
  • Tools to help clinicians extract insights from medical images remain very limited, requiring most analysis to be done manually.
  • At a time when the most powerful insights come at the intersection of diverse data sets (medical records, lab tests, genomics, etc.), medical images remain largely disconnected from mainstream health information.

IBM plans to leverage the Watson Health Cloud to analyze and cross-reference medical images against a deep trove of lab results, electronic health records, genomic tests, clinical studies and other health-related data sources, already representing 315 billion data points and 90 million unique records.  Merge’s clients could compare new medical images with a patient’s image history as well as populations of similar patients to detect changes and anomalies. Insights generated by Watson could then help healthcare providers in fields including radiology, cardiology, orthopedics and ophthalmology to pursue more personalized approaches to diagnosis, treatment and monitoring of patients.

Cutting-edge image analytics projects underway in IBM Research’s global labs suggest additional areas where progress can be made.  They include teaching Watson to filter clinical and diagnostic imaging information to help clinicians identify anomalies and form recommendations, which could help reduce physician viewing loads and increase physician effectiveness.

“As Watson evolves, we are tackling more complex and meaningful problems by constantly evaluating bigger and more challenging data sets,” Kelly said. “Medical images are some of the most complicated data sets imaginable, and there is perhaps no more important area in which researchers can apply machine learning and cognitive computing.  That’s the real promise of cognitive computing and its artificial intelligence components – helping to make us healthier and to improve the quality of our lives.”

Watson Health and Merge Capabilities Will Benefit Researchers, Clinicians and Individuals
IBM’s Watson Health unit plans to bring together Merge’s product and solution offerings with existing expertise in cognitive computing, population health, and cloud-based healthcare intelligence offerings to:

  • Offer researchers insights to aid clinical trial design, monitoring and evaluation;
  • Help clinicians to efficiently identify options for the diagnosis, treatment  and monitoring a broad array of health conditions such as cancer, stroke and heart disease;
  • Enable providers and payers to integrate and optimize patient engagement in alignment with meaningful use and value-based care guidelines; and
  • Support researchers and healthcare professionals as they advance the emerging discipline of population health, which aims to optimize an individual’s care by identifying trends in large numbers of people with similar health status.

“Merge is widely recognized for delivering market leading imaging workflow and electronic data capture solutions,” said Justin Dearborn, chief executive officer, Merge. “Today’s announcement is an exciting step forward for our employees and clients. Becoming a part of IBM will allow us to expand our global scale and deliver added value and insight to our clients through Watson’s advanced analytic and cognitive computing capabilities.”

“Combining Merge’s leading medical imaging solutions with the world-class machine learning and analytics capabilities of IBM’s Watson Health is the future of healthcare technology,” said Michael W. Ferro, Jr., Merge’s chairman. “Merge’s leading technology and proven expertise represent a unique combination of assets that will deliver unparalleled value to Watson Health clients. Together, we will unlock unprecedented new opportunities to improve patient diagnostics and deliver enhanced care.”

About Merge
Merge is a leading provider of innovative enterprise imaging, interoperability and clinical systems that seek to advance healthcare. Merge’s enterprise and cloud-based technologies for image intensive specialties provide access to any image, anywhere, any time. Merge also provides clinical trials software with end-to-end study support in a single platform and other intelligent health data and analytics solutions. With solutions that have been used by providers for more than 25 years, Merge is helping to reduce costs, improve efficiencies and enhance the quality of healthcare worldwide. For more information, visit merge.com and follow us @MergeHealthcare.

IBM Watson: Pioneering a New Era of Computing
Watson is the first commercially available cognitive computing capability representing a new era in computing. The system, delivered through the cloud, analyzes high volumes of data, understands complex questions posed in natural language, and proposes evidence-based answers. Watson continuously learns, gaining in value and knowledge over time, from previous interactions.

In January 2014, IBM launched the IBM Watson unit, a business dedicated to developing and commercializing cloud-delivered cognitive computing technologies. The move signified a strategic shift by IBM to deliver a new class of software, services and apps that improves by learning, and discovers insights from massive amounts of Big Data.  As part of the unit, the company has increased the number and diversity of cognitive computing services delivered to its partners, adding new beta Watson services in February 2015, and scalable deep learning APIs with the acquisition of AlchemyAPI in March 2015.

In April 2015, the company continued to build on its strengths in cognitive computing, analytics, security and cloud with the launch of IBM Watson Health and the Watson Health Cloud platform.  The new unit will help improve the ability of doctors, researchers and insurers to innovate by surfacing new insights from the massive amount of personal health data being created daily.  The Watson Health Cloud allows this information to be anonymized, shared and combined with a dynamic and constantly growing aggregated view of clinical, research and social health data.

About IBM
For more information on IBM Watson, visit: ibm.com/watson.  For more information on IBM Watson Health, visit: ibm.com/watsonhealth

Check out the IBM Watson press kit at: http://www-03.ibm.com/press/us/en/presskit/27297.wss

Join the conversation at #ibmwatson and #watsonhealth. Follow Watson on Facebook and see Watson on YouTube and Flickr.

Learn more about this story at: http://asmarterplanet.com/blog/2015/08/seeing-believing-bringing-cognitive-image-analytics-healthcare.html

– See more at: http://www.merge.com/News/Article.aspx?ItemID=660#sthash.YZ8EBkQT.dpuf

August 6, 2015 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 10 blogs containing over 8000 articles with John having written over 4000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 16 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

Apervita and Mayo Clinic to Create First Self-Service Marketplace for Health Measures

The marketplace is a one-stop-shop to author, publish, and apply measures, allowing users to connect their data to open standard measure definitions

Chicago (June 2, 2015) Apervita, Inc. (apervita.com), the world’s fastest growing health analytics & data community and marketplace, today announced it will expand its platform capabilities to enable any health professional to publish or subscribe to standard, as well as custom, health measures. The new capability automatically transforms measure definitions into computable analytics and is being developed with Mayo Clinic (mayoclinic.org) contributing its expertise in medical care, know how, and technology.

Today, there are already thousands of health measures for quality, safety, outcomes, and finance, with many more to come. These are increasingly the basis for measurement of performance and reimbursement for value-based care. Unfortunately, they are notoriously complex and organizations struggle with the costly process of implementing and maintaining them. This often results in delays of more than 12 months to report new measures or update existing measures. With this new approach, Apervita will offer a family of open interfaces, including open web service APIs, allowing standard measure definitions to be imported, edited, published, executed and exported. Once an author has developed a measure, it can be easily connected to different data sets as well as shared through a global marketplace. Measure results can be displayed on the Apervita platform or accessed through APIs for display within EMRs, third-party systems and mobile applications. The import and export of measures supports the Centers for Medicare and Medicaid Services (CMS) Quality Data Model (QDM) through which all modern measures are today made available.

“There is already an abundance of health measures that support national, state and local objectives, but creating and deploying them can be a daunting task for any health enterprise. With this new capability, Apervita will serve as a platform for standard health measures, facilitating the distribution and execution of expertly developed and conveniently packaged measure sets,” said Paul Magelli, CEO of Apervita. “Apervita subscribers can conveniently browse measures and build their own measure sets, implementing them across their entire organization to monitor and improve performance. No more costly hours spent designing and coding health measures based on individual interpretations of a published standard. For the first time, the entire organization can concentrate on delivering performance excellence, while the development of standard measures are left to subject matter experts.”

“Healthcare providers and facilities should focus on what they do best, providing high quality patient care. After all, that’s what health care measures are designed to enable,” said Dr. Jyotishman Pathak Ph.D., Professor of Biomedical Informatics at Mayo Clinic. “With thousands of health care measures which continuously evolve, keeping track of, implementing and monitoring the measures has shifted some of that focus away from the patients, and it needs to shift back.”

Mayo Clinic and Dr. Jyotishman Pathak have a financial interest in the technology referenced in this news release.

About Apervita

Apervita is the leading health analytics & data community and marketplace, where prominent health professionals and enterprises from around the globe are being empowered to democratize the world’s health analytics and data to improve outcomes and deliver better health for everyone.

At Apervita, we believe that health professionals and enterprises have already created the greatest wealth of knowledge that has ever existed. Today, the majority of this knowledge is paper-based or locked into proprietary systems. The Apervita community is already unlocking them, turning them into 1,000s of computable and shareable analytics and applying them to improve health.

Apervita enables health professionals and enterprises to author, use, publish and apply apply a market of evidence-based algorithms, measures, pathways, protocols and data sets easily connecting them to data and workflow. Available to every health professional and powerful enough for the entire health enterprise, Apervita provides health analytics at a tenth of today’s cost, in a hundredth of the time.

About Mayo Clinic

Mayo Clinic is a nonprofit organization committed to medical research and education, and providing expert, whole-person care to everyone who needs healing. For more information visit mayoclinic.com or newsnetwork.mayoclinic.org.

June 2, 2015 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 10 blogs containing over 8000 articles with John having written over 4000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 16 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

Quality Systems, Inc. Acquires Gennius, Inc.

Acquisition to provide new enterprise analytics capabilities for QSI’s Subsidiary, Mirth

IRVINE, Calif.–(BUSINESS WIRE)– Quality Systems, Inc. (NASDAQ: QSII), announced today it has acquired Gennius, a leading provider of healthcare data analytics. The acquisition is expected to enhance the Company’s current enterprise analytics competencies while broadening its business intelligence capabilities for addressing new value-based care requirements.

Founded in 2002, Cambridge, Mass.-based Gennius is a healthcare analytics company with capabilities to harmonize data to prepare and compute utilization and quality analyses of integrated patient, administrative, and financial data across medical settings and time periods. Its solutions generate comprehensive performance information needed to successfully support provider organizations under new coordinated delivery and reimbursement models.

Gennius’ data analytics engine embeds industry specifications as well as payer contract requirements into functionality that provides prioritized actionable insight into patient care, population health and ACO community performance. This includes computing and submitting measurement results for reporting programs, such as Meaningful Use (MU), Accountable Care Organizations (ACO), Group Practice Reporting Option (GPRO) and Physician Quality Reporting System (PQRS).

“Gennius is pleased to join forces with QSI and its subsidiaries, Mirth and NextGen Healthcare,” said Bernadette Downey, former chief executive officer for Gennius, Inc. “By combining our engineering expertise and methodologies with Mirth’s premier open source connectivity tools and powerful visualization console, we are able to provide customers with access to an unparalleled enterprise system. The system affords users an in-depth data-driven approach to care and helps healthcare community teams align their efforts, succeed in meeting their financial goals and deliver on their population health initiatives.”

“Utilization and quality of care remain consistent focuses of value-driven organizations. To remain viable, value-driven organizations like ACOs must find ways to leverage agile solutions that can scale and adapt to industry demands, dictated by evolving value-based and coordinated care initiatives,” said Steve Plochocki, president and chief executive officer for QSI. “By integrating Gennius’ extensive data analytics and reporting capabilities with NextGen Healthcare and Mirth solutions, we are bringing to market the analytics-based enterprise system needed to provide actionable data intelligence to all agents involved in the community of care delivery. This further strengthens the position of the company and that of our clients for continued success and growth amid the new pay for performance arena.”

About Quality Systems, Inc.

Irvine, Calif.-based Quality Systems, Inc. and its NextGen Healthcare subsidiary develop and market computer-based practice management, electronic health records and revenue cycle management applications as well as connectivity products and services for medical and dental group practices and small hospitals. Visit www.qsii.com and www.nextgen.com for additional information.

April 9, 2015 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 10 blogs containing over 8000 articles with John having written over 4000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 16 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

Caradigm Identity Access Management Solution Certified for Use With FairWarning’s Patient Privacy Monitoring System

BELLEVUE, WA – Mar. 17, 2015Caradigm, the leader in enterprise population health, today announced that Caradigm Provisioning has achieved certification in the FairWarning Ready® for Identity Management program, creating an integrated solution that offers healthcare organizations enhanced data privacy monitoring and alerting.

Hospitals using Caradigm Provisioning with the FairWarning® Patient Privacy Monitoring Platform (“FairWarningPlatform”) will be able to more rapidly determine if there is inappropriate access to patient records when they receive alerts and then take actions to remediate the problem.

“Operating Caradigm Provisioning and the FairWarning Platform together has enhanced our organization’s ability to proactively discover, respond to, and mitigate potential security incidents,” said Vincent Berretta, manager of security for Virtua, one of New Jersey’s largest health systems. “As a result, Virtua has been able to further solidify our overall security posture.”

Part of Caradigm’s suite of Identity and Access Management solutions for healthcare, Caradigm Provisioning helps healthcare organizations minimize security and compliance risk through role-based management of user identity. By codifying access and entitlement rights for the organization in a central repository, and by managing the creation, modification and termination of user access to clinical and core systems, Caradigm Provisioning helps organizations protect patient data while giving their clinicians rapid access to the applications and information they need to perform their jobs.

“Healthcare organizations are facing unprecedented risks to patient privacy and security, and they’re not fully prepared to manage that risk,” said Ralf Klein, vice president, identity and access management, Caradigm. “Caradigm’s collaboration with FairWarning® will give health systems the comprehensive tools they need to quickly pinpoint security issues and take steps to rectify them.”

FairWarning Ready® for Identity Management is a comprehensive program designed to help hospital customers make better use of their existing investment in IT infrastructure. The FairWarning Ready® for Identity Management program enables identity management application vendors to seamlessly integrate with FairWarning® Patient Privacy Monitoring to provide customers with advanced privacy monitoring and alerting.

“By leveraging identity management investments, healthcare providers are able to dramatically reduce the time and effort required to integrate key user identity data and deliver sustainable compliance through their patient privacy monitoring program,” said Shane Whitlatch, FairWarning enterprise vice president.

Customers that integrate Caradigm Provisioning with the FairWarning Platform now have the following capabilities when privacy alerts are triggered:

  • Caradigm’s Provisioning solution provides FairWarning® with a more complete view of the users accessing systems through a daily import of provisioned users.The additional information, including their location, department, role, telephone number, email address, manager’s name, etc. provides the security and privacy managers need when performing an investigation.
  • Using Caradigm’s Provisioning solution, security officers can then take critical security actions, such as suspending all access to clinical applications until the investigation of the person in question is complete; modifying access rights to certain pieces of the clinical application; or removing all access completely from that clinical application.
  • By alerting security officers with potential problems, providing them with additional information and empowering them to take critical actions, Caradigm and FairWarning® can now provide customers with a more complete lifecycle of patient privacy protection.

With customers representing over 7,000 facilities globally, FairWarning® is seeing increased investment in identity management infrastructure across the healthcare industry. The FairWarning® Ready program focuses on partnering with identity management vendors who have demonstrated a track record of customer success in the healthcare industry, to speed and improve patient privacy monitoring deployments and to protect against inadvertent, criminal and fraudulent misuse of electronic health records.

About FairWarning®

FairWarning®’s mission is to lead the industry expansion of trust in Electronic Health Records empowering care providers to grow their reputation for protecting confidentiality, scale their digital health initiatives and comply with complex Federal and state privacy laws such as HIPAA. By partnering with FairWarning®, care providers are able to direct their focus on delivering the best patient outcomes possible while receiving expert, sustainable and affordable privacy and compliance solutions. Customers consider FairWarning® privacy auditing solutions essential for compliance with healthcare privacy regulations such as ARRA HITECH privacy and meaningful use criteria, HIPAA, UK and EU Data Protection, California SB 541 and AB 211, Texas HB 300, and Canadian provincial healthcare privacy law. For more information on FairWarning® visit http://www.FairWarning.com or email Solutions@FairWarning.com.

About Caradigm

Caradigm is a population health company dedicated to helping organizations improve care, reduce costs, and manage risk. Caradigm analytics solutions provide insight into patients, populations, and performance, enabling healthcare organizations to understand their clinical and financial risk and identify the actions needed to address it. Caradigm population health solutions enable teams to deliver the appropriate care to patients through effective coordination and patient engagement, helping to improve outcomes and financial results. The key to Caradigm analytics and population health solutions is a rich set of clinical, operational, and financial data delivered to healthcare professionals within their workflows in real time. Learn more at: www.caradigm.com.

March 17, 2015 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 10 blogs containing over 8000 articles with John having written over 4000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 16 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

Exostar Reaches New Milestones with Life Sciences Identity Hub

Community Expands into Healthcare, Medical Device Markets; Company Formally Launches Partner Program

HERNDON, VA, February 4, 2015Exostar, an innovative information technology company offering cloud-based solutions that enable secure, cost-effective business-to-business collaboration, today announced its Life Sciences Identity Hub attained key milestones over the second half of 2014, including the following:

  • 40% Increase in Connected Organizations – Nearly 700 companies, such as manufacturers, contract research organizations, and laboratories, are active participants in Exostar’s hybrid cloud community.
  • 50% Increase in Academic Institutions – Over 60 universities are collaborating with life sciences organizations to speed the drug research and development process.
  • 50% Increase in Engaged Users – Almost 15,000 individuals are executing business-critical efforts through the Life Sciences Identity Hub.
  • Expansion into New Markets – The Exostar community now encompasses health IT vendors, healthcare providers, and medical device manufacturers who are helping bring life-altering and life-saving therapies to patients through solutions like electronically prescribed controlled substances.

Exostar’s Life Sciences Identity Hub is a cloud-based, connect-once solution delivered as-a-Service.  As a result, Exostar handles all organization and individual on-boarding, user authentication, and application connection and access enforcement requirements.  Organizations can mitigate risk and minimize the burden on their IT resources to establish the collaborative operating environments they desire.  Individuals benefit from a single sign-on user experience and secure access to the applications and information they need to conduct business with colleagues inside and outside of the enterprise.

“Organizations in life sciences and healthcare are adopting an external partner business model to reduce cost, ensure compliance, and get new drugs to market as quickly as possible,” said Daniel Pfeifle, Exostar’s Vice President of Sales and Marketing.  “These companies are embracing our proven, scalable Life Sciences Identity Hub because it allows them to engage and productively collaborate beyond enterprise boundaries faster and more securely than virtually any other alternative.”

In response to demand for improved cloud access in the Life Sciences and Aerospace and Defense industries, Exostar has launched a new partner program to extend the company’s reach and the value of participating in the community.  The partner program formalizes the relationships with current partners and lays the foundation for the immediate addition of application partners, reseller partners, technology suite partners, and strategic alliance partners.

To oversee the growth of this strategic initiative, Exostar has hired a new Director of Global Partnerships and Alliances, Kevin O’Brien.  O’Brien brings over 25 years of business development and technology experience to his position, where he will be responsible for the planning and execution of the Exostar partner program.  He comes to Exostar from Sprint Nextel, where he spent nine years crafting multi-million dollar relationships with Microsoft, Cisco, IBM, Alcatel-Lucent, and other global market leaders.

About Exostar

Exostar powers secure business-to-business information sharing, collaboration and business process integration throughout the value chain.  Exostar supports the complex trading needs of many of the world’s largest companies in aerospace and defense, life sciences, and other industries.  Exostar’s cloud-based identity assurance products and business applications reduce risk, improve agility and strengthen trading partner relationships and profitability for over 100,000 companies in 150 countries worldwide.  The Exostar community includes market leaders such as AstraZeneca, BAE Systems, Bell Helicopter, The Boeing Company, Computer Sciences Corporation, Lockheed Martin Corp., Merck, Newport News Shipbuilding, Northrop Grumman, Raytheon Co. and Rolls-Royce.  For more information, please visit www.exostar.com.

February 4, 2015 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 10 blogs containing over 8000 articles with John having written over 4000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 16 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

FDB Releases Web API Solution to Enable Fast, Reliable and Secure Access to FDB Drug Knowledge in the Cloud

First-to-market cloud-based solution for integrated medication decision support enables users to access and deploy the latest drug knowledge in vastly reduced development timeframes

South San Francisco, CA January 29, 2015 – First Databank (FDB), the leading provider of clinical drug knowledge that improves medication-related decisions and patient outcomes, today announced the general release of the FDB Cloud Connector, a web API solution that effectively delivers FDB’s vast drug knowledge through high performing and highly available web services that are easily integrated into today’s mission-critical healthcare applications from client-server to mobile.

Healthcare has been slow to adopt the Cloud, but with healthcare reform, that trend is rapidly changing. According to a 2014 HIMSS Analytics Cloud Survey, more than 80% of providers are already using the cloud and nearly 60% of all healthcare CIO’s see the cloud as a strategic and operational necessity. With the dramatic reductions in development time and IT overhead that come from using a web API, many healthcare organizations are turning to this technology as a means to keep up with never-ending demands on limited IT resources. Web services can be easily deployed through client-server and web-based applications, and mobile application developers can now more easily develop native mobile apps to support the growing number of patient encounters that will be conducted over smart devices.

The FDB Cloud Connector, based on state-of-the art architecture which includes high-performing and highly available web services powered by Amazon Web Services, offers a host of user benefits for health IT system developers. It allows customers to request and receive FDB drug knowledge, as needed, without the complexity of hosting and updating data and software, or having to develop the means to redistribute. The web API solution also significantly reduces development timelines enabling applications to be released to the market more quickly. And the FDB Cloud Connector provides users with the flexibility to easily bolt on individual services to their existing applications to take advantage of FDB’s latest capabilities without the need to manage a large software upgrade.

“As cloud-based services are steadily becoming more widely adopted by healthcare organizations globally, we are excited to be the first in our industry to offer cloud-based delivery of integrated drug knowledge to our customer base,” said Chuck Tuchinda, MD, MBA, president, FDB. “With the FDB Cloud Connector, we have created an opportunity to vastly improve application development times so that our customers are able to immediately and securely deploy the most current FDB drug knowledge and, ultimately, enhance medication care guidance.”

After testing with several large information system vendor partners, the new delivery option is now generally available to FDB customers. “The FDB Cloud Connector allows us to deliver a huge amount of drug data through the web” said Larry O’Toole, associate vice president of strategy at MEDITECH. “FDB, MEDITECH, and our customers continue to benefit from such collaborations.”

Data delivery through web services in the cloud will also ease the implementation of next generation clinical decision support such as pharmacogenomics data. These large data sets with complex algorithms may be impractical to deliver via traditional means and the FDB Cloud Connector is expected to facilitate the adoption of these new capabilities.

About First Databank (FDB)
FDB (First Databank), part of the Hearst Health network, is the leading provider of drug knowledge that helps healthcare professionals make precise medication-related decisions. With thousands of customers worldwide, FDB enables our information system developer partners to deliver a wide range of valuable, useful, and differentiated solutions. As the company that virtually launched the medication decision support category, we offer more than three decades of experience in transforming drug knowledge into actionable, targeted, and effective solutions that improve patient safety and healthcare outcomes. For a complete look at our solutions and services please visit http://www.fdbhealth.com or follow us on Twitter and LinkedIn.

About Hearst Health
FDB is part of the Hearst Health network, which also includes Zynx Health, MCG (formerly Milliman Care Guidelines) and Homecare Homebase. The mission of the Hearst Health network is to help guide the most important care moments by delivering vital information into the hands of everyone who touches a person’s health journey. Each year in the U.S., care guidance from the Hearst Health network reaches 76% of discharged patients, 133 million insured individuals, 20 million home health visits, 1.88 billion retail pharmacy prescriptions and 3.26 billion prescription claims. Extensions of the Hearst Health network include Hearst Health Ventures and the Hearst Health Innovation Lab.

January 29, 2015 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 10 blogs containing over 8000 articles with John having written over 4000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 16 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.